Bipolar disorder

A wearable lithium drug monitor developed by the University of Surrey could change the lives of patients who suffer from bipolar and depression.

A global team of researchers have identified 30 areas of the human genome where variations in genetic code can increase the risk of developing bipolar disorder.

A new study finds that the protein CPG2 is significantly less abundant in the brains of people with bipolar disorder (BD) and shows how specific mutations in the SYNE1 gene that encodes the protein undermine its expression and its function in neurons.

People living with bipolar disorder and depression will soon be able to use a unique wearable sensor to safely monitor their lithium drug levels.

Study finds apparent benefits of addition of adjunctive antidepressants to mood stabilizers, Tel Aviv University researchers say

Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the drug lithium

Evidence suggests that sleep loss, as well as being a core symptom and early warning sign of impending mood episodes in people with bipolar disorder, can also trigger relapse, particularly mania.

People with bipolar disorder often find themselves unemployed due to exclusion, prejudice and stereotypes directed at them at work, a new study found